Remco Hoogenboezem

Remco Hoogenboezem is a Researcher in the Department of Hematology at Erasmus University Rotterdam's Faculty of Medicine. His work focuses on cutting-edge research in hematology, immunology, and transcriptomics, with particular emphasis on myeloid disorders, multiple myeloma, and GATA2 deficiency syndrome.

Dr. Hoogenboezem's research interests span several critical areas in hematology and immunology. His work on transcriptional profiling of acute leukemias has advanced diagnostic approaches for ambiguous lineage cases. He has made significant contributions to understanding the role of NK cells in multiple myeloma treatment response and has investigated the pathophysiological mechanisms underlying GATA2 deficiency syndrome. His recent work using single-cell transcriptomics to explore immune-structural cell interactions in cystic fibrosis demonstrates the breadth of his research capabilities across hematological and immunological conditions.

His recent publications demonstrate expertise across multiple subfields including T cell immunology in autoimmune encephalitis, transcriptional classification of leukemias, NK cell profiling in myeloma treatment, GATA2 deficiency pathophysiology, and immune-structural cell crosstalk in cystic fibrosis. These works collectively highlight his focus on applying advanced genomic and transcriptomic techniques to solve complex clinical problems in hematology and immunology.

Dr. Hoogenboezem actively collaborates with numerous researchers across Erasmus MC and international institutions, as evidenced by his co-authorship on multiple high-impact publications in journals such as Blood, Brain, and Journal of Cystic Fibrosis. His research has garnered attention across academic and clinical communities, with several of his publications receiving citations and mentions in news outlets.